Samsung Medison plans to acquire Paris-based startup Sonio for approximately $92.7 million to enhance its capabilities in AI-powered ultrasound technology.

Information on the Target

Samsung Medison, a subsidiary of Samsung Electronics, specializes in the development of diagnostic imaging devices and has announced its intention to acquire Sonio, a startup based in Paris. This acquisition, valued at approximately $92.7 million (KRW 126 billion), will enhance Samsung Medison's capabilities in the field of AI-driven ultrasound technology.

Founded in 2020 by Cecile Brosset and Rémi Besson, Sonio has developed an AI-powered software solution designed to assist obstetricians and gynecologists in evaluating and documenting ultrasound examinations. The company's flagship product, Sonio Detect, has received FDA regulatory clearance, leveraging deep learning algorithms to significantly enhance ultrasound image quality in real time.

Industry Overview in France

The medical device industry in France is a robust and rapidly evolving sector, which is characterized by significant investments in technology and innovation. This environment is supported by a strong regulatory framework that promotes research